Kura Oncology
KURA
183 hedge funds and large institutions have $531M invested in Kura Oncology in 2025 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 62 increasing their positions, 57 reducing their positions, and 36 closing their positions.
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
9% more repeat investments, than reductions
Existing positions increased: 62 | Existing positions reduced: 57
3% less first-time investments, than exits
New positions opened: 35 | Existing positions closed: 36
7% less call options, than puts
Call options by funds: $596K | Put options by funds: $640K
1% less funds holding
Funds holding: 185 → 183 (-2)
1.74% less ownership
Funds ownership: 101.34% → 99.59% (-1.7%)
23% less capital invested
Capital invested by funds: $686M → $531M (-$155M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
+$40.4M |
| 2 |
SCM
Suvretta Capital Management
New York
|
+$18.4M |
| 3 |
SI
Sofinnova Investments
Menlo Park,
California
|
+$6.17M |
| 4 |
AC
Armistice Capital
New York
|
+$6.02M |
| 5 |
PM
Prosight Management
Dallas,
Texas
|
+$5.87M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACA
Avoro Capital Advisors
New York
|
-$19.6M |
| 2 |
SL
Siren LLC
Greenwich,
Connecticut
|
-$11.7M |
| 3 |
Morgan Stanley
New York
|
-$10.5M |
| 4 |
EC
EcoR1 Capital
San Francisco,
California
|
-$7.15M |
| 5 |
BNP Paribas Asset Management
Paris,
France
|
-$6.05M |
KURA Hedge Fund Activity: Q1 2025 in Review
183 of the 7,472 institutional investors tracked by Wall St. Rank reported a position in Kura Oncology (KURA) for Q1 2025, worth a combined $531M — down 23% from $686M a quarter earlier.
Sellers outnumbered buyers: 36 funds closed out of KURA and 35 opened new positions — a net loss of 1 holder — while 57 trimmed existing stakes and 62 added.
The largest buyer was BVF Inc, adding an estimated $40.4M. The largest seller was Avoro Capital Advisors, exiting entirely with an estimated $19.6M sold.
- 183 institutional investors held Kura Oncology (KURA) as of Q1 2025, down from 185 in Q4 2024.
- Funds reported $531M of Kura Oncology stock for Q1 2025, down 23% quarter-over-quarter.
- 35 funds opened new Kura Oncology positions in Q1 2025 and 36 closed out, a net change of -1 holder.
- The largest Kura Oncology buyer in Q1 2025 was BVF Inc, an estimated $40.4M added.
- The largest Kura Oncology seller in Q1 2025 was Avoro Capital Advisors, an estimated $19.6M sold.
Based on aggregated 13F filings for Q1 2025.